Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 451

1.

Changing smokeless tobacco products new tobacco-delivery systems.

Hatsukami DK, Ebbert JO, Feuer RM, Stepanov I, Hecht SS.

Am J Prev Med. 2007 Dec;33(6 Suppl):S368-78. Review.

PMID:
18021912
2.

Snuffing out cigarette sales and the smoking deaths epidemic.

Laugesen M.

N Z Med J. 2007 Jun 15;120(1256):U2587. Review.

PMID:
17589555
3.

Supping with the devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products.

Hall W, Gartner C.

Public Health. 2009 Mar;123(3):287-91. doi: 10.1016/j.puhe.2008.12.018. Epub 2009 Feb 15.

PMID:
19223052
4.

Smokeless tobacco: a gateway to smoking or a way away from smoking.

Melikian AA, Hoffmann D.

Biomarkers. 2009 Jul;14 Suppl 1:85-9. doi: 10.1080/13547500902965401. Review.

PMID:
19604066
5.

Epidemiologic perspectives on smokeless tobacco marketing and population harm.

Tomar SL.

Am J Prev Med. 2007 Dec;33(6 Suppl):S387-97. Review.

PMID:
18021914
6.
7.

Smokeless tobacco: challenges, products and, cessation.

Rankin KV, Jones DL, Benton E.

Tex Dent J. 2010 Jun;127(6):589-94.

PMID:
20629366
8.

Harm reduction policies for tobacco users.

Gartner C, Hall W.

Int J Drug Policy. 2010 Mar;21(2):129-30. doi: 10.1016/j.drugpo.2009.10.008. Epub 2009 Nov 26.

PMID:
19944582
9.

Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.

Mendoza-Baumgart MI, Tulunay OE, Hecht SS, Zhang Y, Murphy S, Le C, Jensen J, Hatsukami DK.

Nicotine Tob Res. 2007 Dec;9(12):1309-23.

PMID:
18058349
10.

Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.

Richter P, Hodge K, Stanfill S, Zhang L, Watson C.

Nicotine Tob Res. 2008 Nov;10(11):1645-52. doi: 10.1080/14622200802412937.

PMID:
18988077
11.

Tobacco, nicotine and harm reduction.

Le Houezec J, McNeill A, Britton J.

Drug Alcohol Rev. 2011 Mar;30(2):119-23. doi: 10.1111/j.1465-3362.2010.00264.x. Review.

PMID:
21375611
12.

Free nicotine content and strategic marketing of moist snuff tobacco products in the United States: 2000-2006.

Alpert HR, Koh H, Connolly GN.

Tob Control. 2008 Oct;17(5):332-8. doi: 10.1136/tc.2008.025247. Epub 2008 Jul 31.

13.

Developing smokeless tobacco products for smokers: an examination of tobacco industry documents.

Carpenter CM, Connolly GN, Ayo-Yusuf OA, Wayne GF.

Tob Control. 2009 Feb;18(1):54-9. doi: 10.1136/tc.2008.026583. Epub 2008 Oct 23. Review.

14.

Smokeless tobacco as a nicotine delivery device: harm or harm reduction?

Benowitz NL.

Clin Pharmacol Ther. 2011 Oct;90(4):491-3. doi: 10.1038/clpt.2011.191. Epub 2011 Aug 10. Review.

PMID:
21934719
15.

Tobacco smoking, harm reduction, and biomarkers.

Shields PG.

J Natl Cancer Inst. 2002 Oct 2;94(19):1435-44. Review.

PMID:
12359853
16.

Should Australia lift its ban on low nitrosamine smokeless tobacco products?

Gartner CE, Hall WD.

Med J Aust. 2008 Jan 7;188(1):44-6.

PMID:
18205564
17.

The potential impact of a low-nitrosamine smokeless tobacco product on cigarette smoking in the United States: estimates of a panel of experts.

Levy DT, Mumford EA, Cummings KM, Gilpin EA, Giovino GA, Hyland A, Sweanor D, Warner KE, Compton C.

Addict Behav. 2006 Jul;31(7):1190-200. Epub 2005 Oct 26.

PMID:
16256276
18.

Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?

Frost-Pineda K, Appleton S, Fisher M, Fox K, Gaworski CL.

Nicotine Tob Res. 2010 Nov;12(11):1055-67. doi: 10.1093/ntr/ntq147. Epub 2010 Sep 16. Review.

PMID:
20847148
19.

Oral health risks of tobacco use and effects of cessation.

Warnakulasuriya S, Dietrich T, Bornstein MM, Casals Peidró E, Preshaw PM, Walter C, Wennström JL, Bergström J.

Int Dent J. 2010 Feb;60(1):7-30. Review.

PMID:
20361572
20.

Smokeless tobacco use: harm reduction or induction approach?

Hatsukami DK, Lemmonds C, Tomar SL.

Prev Med. 2004 Mar;38(3):309-17. Review.

PMID:
14766113

Supplemental Content

Support Center